Emergent Health Corp (EMGE)
| Previous Close | 0.0047 |
| Open | 0.0049 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0047 - 0.0053 |
| 52 Week Range | 0.0030 - 0.0450 |
| Volume | |
| Avg. Volume | 2,212,191 |
| Market Cap | 196,819 |
| Beta (5Y Monthly) | 1.42 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Emergent Health Appoints Former Kraft Foods Director of National Accounts Charlie McMenamin to Its Board of Directors
Emergent Health Corp. (OTC PINK:EMGE), a curator, developer and marketer of products in the Regenerative Health Space announced today the appointment of former Kraft Foods Director of National Accounts Charlie McMenamin to its Board of Directors.
- ACCESSWIRE
Emergent Executes "Letter of Intent" to Acquire Nanosthetic, a Biologics Company That Manufacturers Products to be Sold and Marketed by Evolutionary Biologics
Emergent Health Corp. (OTC PINK:EMGE),a curator, developer and marketer of products in the Regenerative Health Space announced today that it has executed a "Letter of Intent" to acquire Nanosthetic Corp. ("Nanosthetic"), a biologics company that manufacturers products sold and marketed by Emergent subsidiary Evolutionary Biologics.
- ACCESSWIRE
Emergent Intends to Become a Fully Reporting SEC Issuer and List its Shares on the OTCQB
Emergent Health Corp. (OTC PINK:EMGE),a curator, developer and marketer of products in the Regenerative Health Space announced today that it intends to retain an independent certified public accountant to audit Emergents financial statements in accordance with Securities and Exchange Commission ("SEC") Generally Accepted Accounting Principles ("GAAP") and an experienced Securities Attorney to prepare and file either Form 10 or Form S-1 Registration
